International audienceIn a French national cohort of unaffected females carriers/non-carriers of a BRCA1/2 mutation, long-term preventive strategies and breast/ovarian cancer risk perceptions were followed up to 5 years after test result disclosure, using self-administered questionnaires. . Response rate was 74%. Carriers (N=101) were younger (average age ± SD = 37±10) than non-carriers (N=145; 42 ± 12). There were four management strategies that comprised 88% of the decisions made by the unaffected carriers: 50% opted for breast surveillance alone, based on either Magnetic Resonance Imaging (MRI) and other imaging (31%) or mammography alone (19%); 38% opted for either Risk Reducing Salpingo-Oophorectomy (RRSO) and breast surveillance, base...
INTRODUCTION: Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are eith...
This study aimed to ascertain whether cancer risk perception changed following the offer and subsequ...
INTRODUCTION: Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are eith...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...
This prospective multicentre study assesses long-term impact of genetic testing for breast/ovarian c...
Item does not contain fulltextGenetic testing enables women at risk for hereditary breast and/or ova...
Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whethe...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
INTRODUCTION: Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are eith...
INTRODUCTION: Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are eith...
This study aimed to ascertain whether cancer risk perception changed following the offer and subsequ...
INTRODUCTION: Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are eith...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...
International audienceIn a French national cohort of unaffected females carriers/non-carriers of a B...
This prospective multicentre study assesses long-term impact of genetic testing for breast/ovarian c...
Item does not contain fulltextGenetic testing enables women at risk for hereditary breast and/or ova...
Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whethe...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
Female BRCA1/BRCA2 mutation carriers are at substantially increased risk for developing breast and/o...
INTRODUCTION: Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are eith...
INTRODUCTION: Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are eith...
This study aimed to ascertain whether cancer risk perception changed following the offer and subsequ...
INTRODUCTION: Strategies in case of high risk of breast cancer in BRCA1/2 mutation carriers are eith...